1 / 8

Ophthalmology Drugs Market 2023: Industry Top Players, Regions & Market Overview Forecast 2023

"Ophthalmic Drugs Market by Indication, Type, Distribution Channel, Dosage Form, Technology, and Therapeutic Class: Global Opportunity Analysis and Industry Forecast, 2017-2023", the global ophthalmic drugs market was valued at $29,613 million in 2016, and is projected to reach $42,663 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The retinal disorders segment accounted for 26.6% of the global ophthalmic drugs market in 2016.

swati_tamhankar
Télécharger la présentation

Ophthalmology Drugs Market 2023: Industry Top Players, Regions & Market Overview Forecast 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ophthalmology Drugs Market 2023: Industry Top Players, Regions & Market Overview Forecast 2023

  2. OPHTHALMOLOGY DRUGS MARKET Ophthalmic Drugs Market by Indication, Type, Distribution Channel, Dosage Form, Technology, and Therapeutic Class: Global Opportunity Analysis and Industry Forecast, 2017-2023", the global ophthalmic drugs market was valued at $29,613 million in 2016, and is projected to reach $42,663 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The retinal disorders segment accounted for 26.6% of the global ophthalmic drugs market in 2016. Access Full Summary at :https://www.alliedmarketresearch.com/ophthalmic-drugs-market

  3. OPHTHALMOLOGY DRUGS MARKET Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders. According to the American Academy of Ophthalmology, 11 million people in the U.S. suffer from age-related macular degeneration (AMD), while approximately 10% of them are inflicted with wet AMD. Such trends in ophthalmic disorders across the globe contribute to the growth of the market. The development of effective ophthalmic is crucial is the current scenario, owing to increase in incidence of ophthalmic disorders such as glaucoma, cataract, and other common eye infections. Ophthalmic drugs are administered in different dosage forms depending upon the indication. Market players focus on innovation of novel approaches for the development of ophthalmic drugs over the years, including small molecule, biologics, and recombinant technologies, thereby driving the growth of ophthalmic drugs market. Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/310

  4. OPHTHALMOLOGY DRUGS MARKET Indication Segment Review The ophthalmic drugs industry is segmented based on indication into dry eye, glaucoma, infection/inflammation/allergy, retinal disorders, and others. The retinal disorders segment is further classified into wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and others. Retinal disorders indication has registered significant growth rate, registering a CAGR of 5.8% from 2017 to 2023. The dry age-related macular degeneration segment accounts for the highest share among all the retinal disorders in 2016, and is expected to continue this trend throughout the forecast period.

  5. OPHTHALMOLOGY DRUGS MARKET Dosage Form Segment Review The ophthalmic drugs industry analysis is segmented based on dosage form into liquid, solid, semisolid, multicompartment drug delivery systems, and other ophthalmic drug forms. Liquid ophthalmic drug form segment accounted for the highest revenue in 2016, and is projected to maintain the trend throughout the forecast period. However, multicompartment drug delivery systems registered the highest CAGR of 8.0%. This is attributed to increase in development of novel ocular drug delivery approaches including nanoparticles, noisome, and dendrimers.

  6. OPHTHALMOLOGY DRUGS MARKET • By Type • Prescription Drugs • Over-the-Counter Drugs • By Dosage Form • Liquid Ophthalmic Drug Forms • Solid Ophthalmic Drug Forms • Semisolid Ophthalmic Drug Forms • Multicompartment Drug Delivery Systems • Other Ophthalmic Drug Forms • Ophthalmic Drugs Market Key Segments: • By Indication • Dry Eye • Glaucoma • Infection/Inflammation/Allergy • Retinal Disorders • Wet Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Diabetic Retinopathy • Others • Others

  7. OPHTHALMOLOGY DRUGS MARKET • By Therapeutic Class • Anti-glaucoma • Anti-infection • Anti-inflammatory • Anti-allergy • By Geography • North America • Europe • Asia-Pacific • LAMEA • By Technology • Biologics • Cell Therapy • Gene Therapy • Drug Delivery • Small molecule • Others • By Distribution Channel • Hospital Pharmacies • Drug Stores • Online Pharmacies • Others Do Purchase Report: https://www.alliedmarketresearch.com/purchase-enquiry/310

  8. OPHTHALMOLOGY DRUGS MARKET OPHTHALMOLOGY DRUGS MARKET Thank You! For More Details Visit us at https://www.alliedmarketresearch.com OPHTHALMOLOGY DRUGS MARKET Follow Us On

More Related